CASP4 expression tracks fibrosis severity in metabolic dysfunction-associated steatotic liver disease and CASP4-targeting siRNA reduces inflammatory hepatocyte injury
Background Metabolic dysfunction-associated steatotic liver disease (MASLD) involves heterogeneous inflammatory and fibrotic states. We investigated the relationship between CASP4 expression, MASLD severity, and fatty-acid-associated hepatocyte injury. Methods Discovery bulk RNA sequencing included 216 liver samples spanning fibrosis stages F0–F4 (GSE135251), with candidate prioritization informed by an independent 98-biopsy NAFL/NASH cohort (GSE167523). Single-nucleus datasets provided cell-type localization using participant-level summaries (GSE244832) and evaluation across 48 control, MASL, early-MASH, and advanced-MASH participants (GSE289173); an unpaired chromatin-accessibility cohort provided molecular context (GSE281367). CASP4-targeting siRNA was tested in fatty-acid-exposed HepG2 and Huh7 cells using viability, membrane-injury, inflammatory, and apoptosis-associated readouts. Results CASP4 expression increased with fibrosis stage in discovery tissue (β = 0.0800, FDR = 1.41 × 10 −8 ) and was higher in external NASH than NAFL biopsies (β = 0.2146, FDR = 1.06 × 10 −4 ). The hepatocyte ordered-stage coefficient was positive (β = 0.02394, FDR = 0.0373), with weaker support after sex adjustment (FDR = 0.0647) and a nonsignificant categorical-stage test. The largest within-state estimate was observed in pericentral hepatocytes. In HepG2 and Huh7 cells, oleic acid/palmitic acid exposure increased CASP4 mRNA and injury. The selected CASP4-targeting siRNA improved viability and reduced LDH release; in HepG2 cells it also reduced inflammatory outputs, Annexin V positivity, and cleaved caspase-3 fluorescence. Conclusion These findings link severity-associated CASP4 expression to an siRNA-associated inflammatory injury phenotype in fatty-acid-exposed hepatocyte-derived cells.
Authors
- Feng Liang (ORCID: https://orcid.org/0009-0008-7704-3435)
- Min Shi (ORCID: https://orcid.org/0000-0003-0113-4089)
- Jie Gou
- Wenjuan Wang
- Wan’e Wang
- Yingyu Xie
Institutions
- Huaian First People’s Hospital (CN)
- Jinhua Academy of Agricultural Sciences (CN)
- Second People’s Hospital of Huai’an (CN)
- Huai'an City Fourth People's Hospital (CN)
- Jinhua Central Hospital (CN)
- Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University (CN)
- Zhejiang University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Cell and Developmental Biology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fcell.2026.1996421
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00